Percutaneous endoscopic gastrostomy (PEG) tube feeding in patients with esophageal cancer scheduled for chemoradiotherapy

Not Applicable

Active, not recruiting

• Conditions: Esophageal cancer; Nutrition; Diet and Nutrition - Other diet and nutrition disorders; Cancer - Oesophageal (gullet)

• Registration Number: ACTRN12616000697482
• Lead Sponsor: Instituto Portugues de Oncologia de Lisboa Francisco Gentil

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-05-26
• Last Update Posted: 23 March 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 29

Inclusion Criteria

Patients with esophagus cancer (squamous cell carcinoma and adenocarcinoma) and esophageal-gastric junction cancer, Siewert I, (adenocarcinoma) with dysphagia (grade> 2) and/or weight loss (> 10% normal body weight), proposed for definitive or neoadjuvant CRT

Exclusion Criteria

Contraindications for PEG placement:
- patients with no ability to take care of PEG,
- decompensated chronic liver disease,
- presence of clinically significant ascites.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assess the impact of PEG placement in the nutritional status of patients with esophageal cancer proposed to chemoradiotherapy (CRT) <br>--> measured by: BMI fluctuation:<br> - if esophagectomy: before surgery-diagnosis; <br> - if definitive CRT: post-therapeutic-diagnosis<br><br>BMI= weight in kilograms divided by the square of height in meters[- if esophagectomy: before surgery-diagnosis<br>- if definitive CRT: post-therapeutic-diagnosis]